Sort
15,842 grants matching “pancreatic cancer”
Elucidating the mechanism of Ga13 mediated tumor suppression in pancreatic cancer
$405,234Mario Shields · State University New York Stony Brook · R01 · FY2024 · CA
Targeting PKR-Bcl2 Signaling to Overcome Paclitaxel Resistance in Ovarian Cancer
$405,163Jixin Dong · University Of Nebraska Medical Center · R01 · FY2023 · CA
MRI Capable Receptor Targeted Drug Delivery for Pancreatic Cancer
$405,027Hui Mao · Emory University · R01 · FY2011 · CA
Chromatin Dynamics and Genome Regulation
$405,000Laura Banaszynski · Ut Southwestern Medical Center · R35 · FY2018 · GM
Chromatin Dynamics and Genome Regulation
$405,000Laura Banaszynski · Ut Southwestern Medical Center · R35 · FY2017 · GM
Chromatin Dynamics and Genome Regulation
$405,000Laura Banaszynski · Ut Southwestern Medical Center · R35 · FY2020 · GM
Chromatin Dynamics and Genome Regulation
$405,000Laura Banaszynski · Ut Southwestern Medical Center · R35 · FY2019 · GM
Chromatin Dynamics and Genome Regulation
$405,000Laura Banaszynski · Ut Southwestern Medical Center · R35 · FY2021 · GM
Animal Core
$404,995Hidekazu Tsukamoto · University Of Southern California · P50 · FY2023 · AA
Targeting Oncogenic Ras-MAPK Signaling Complexes via the Scaffold KSR
$404,930Arvin Dar · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · CA
Regulation of the Class IA PI 3-kinase PIK3CB
$404,897Jonathan M. Backer · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · GM
Regulation of the Class IA PI 3-kinase PIK3CB
$404,897Jonathan M. Backer · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · GM
Regulation of the Class IA PI 3-kinase PIK3CB
$404,893Jonathan M. Backer · Albert Einstein College Of Medicine · R01 · FY2014 · GM
Cognitive Impairment, Multimorbidity, and end-of-life care in older cancer patients
$404,835Stanton L Gerson · Case Western Reserve University · P30 · FY2020 · CA
ROLES AND MECHANISMS OF TERTIARY LYMPHOID STRUCTURES IN ANTI-TUMOR IMMUNITY
$404,798Andrew Gunderson · Ohio State University · R01 · FY2024 · CA
Targeting aberrant enhancer landscapes in pancreatic cancer
$404,792Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2022 · CA
Targeting aberrant enhancer landscapes in pancreatic cancer
$404,792Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2023 · CA
REU Site: Characterization of Materials Using Synchrotron and X-ray Based Tools
$404,776Amir Mostafaei · Illinois Institute Of Technology · · FY2021 · MPS
Multi-site Gastrointestinal Cancer Detection by Stool DNA Methylation
$404,684John Kisiel · Mayo Clinic Rochester · R37 · FY2022 · CA
Multi-site Gastrointestinal Cancer Detection by Stool DNA Methylation
$404,684John Kisiel · Mayo Clinic Rochester · R37 · FY2018 · CA
Multi-site Gastrointestinal Cancer Detection by Stool DNA Methylation
$404,684John Kisiel · Mayo Clinic Rochester · R37 · FY2020 · CA
ELUCIDATION & MODULATION OF NATURAL KILLER CELL SIGNALING: APPLICATION IN CANCER
$404,651Michael A Caligiuri · Ohio State University · P01 · FY2008 · CA
Exploiting tumor stroma interactions for cancer therapy
$404,625Garth Powis · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2015 · CA
Exploiting tumor stroma interactions for cancer therapy
$404,625Garth Powis · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2016 · CA
A Clinical Center to Study Immunological and Hormonal Biomarkers for the Diagnosis, Prediction and Treatment of Chronic Pancreatitis and its associated development to Diabetes and Pancreas Cancer
$404,605Walter Gwang-Up Park · Stanford University · U01 · FY2017 · DK